by (1) adding the supernatant liquid of cultured Epstein-Barr virus (EBV) strain to human lymphocyte, (2) culturing and transforming the obtained EBV-infected lymphocyte, (3) separating a cell strain reactive to HA antigen of influenza virus A from the resultant B-type lymphoblastoid cell and...